Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation
July 26, 2022 07:30 ET
|
Diffusion Pharmaceuticals Inc.
Diffusion aligns with FDA on design of an open-label, dose-escalation, Phase 2 safety and efficacy study of trans sodium crocetinate (“TSC”) in newly diagnosed glioblastoma multiforme (“GBM”)...
Ivy Brain Tumor Center at Barrow Neurological Institute Launches Spanish-Language Website
June 15, 2022 09:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, June 15, 2022 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, a nonprofit early-phase drug development program for brain cancer, has announced the...
Brain Cancer Canada funds Canada's first genomics technology for rapid and precise brain tumour diagnostics
May 01, 2022 09:00 ET
|
Brain Cancer Canada
TORONTO, May 01, 2022 (GLOBE NEWSWIRE) -- Today marks the first day of Brain Cancer Awareness month. On this day Brain Cancer Canada grants $100,000 to the St. Michael's Hospital program to acquire...
Ivy Brain Tumor Center Opens New Clinical Trial for Patients with Recurrent Grade IV Gliomas
March 16, 2022 10:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, March 16, 2022 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer, announced the opening...
Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer Imaging Study
December 21, 2021 19:49 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a clinical data access agreement with...
Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 by DelveInsight
December 13, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Glioblastoma Pipeline Analysis | Clinical Trials Report 2021 | DelveInsight There are approximately 150+ key companies developing Glioblastoma...
StacheStrong Raises $340,000 for the Ivy Brain Tumor Center’s Innovative Phase 0 Clinical Trial of Sonodynamic Therapy for Patients with Glioblastoma
December 01, 2021 13:08 ET
|
StacheStrong
VESTAL, NY, Dec. 01, 2021 (GLOBE NEWSWIRE) -- StacheStrong, a non-profit devoted to raising funds and awareness for brain cancer research, and Barrow Neurological Foundation, announced they raised...
Brain Cancer Canada To Fund Barrier Breaking Chemistry Research Targeting Glioblastoma
November 30, 2021 08:30 ET
|
Brain Cancer Canada
TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- A pioneering approach led by Prof. Patrick Gunning at the University of Toronto, leveraging advanced medicinal chemistry to help develop potential...
Ivy Brain Tumor Center Collaborates with GSK on New Phase 0 Clinical Trial to Evaluate Niraparib in Patients with Brain Cancer
November 02, 2021 07:00 ET
|
Ivy Brain Tumor Center
PHOENIX, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute and UC San Francisco announced the opening of a Phase 0 clinical trial to evaluate...
Brain Cancer Canada Funds Canadian Research Aiming To Treat Brain Cancer
October 24, 2021 09:00 ET
|
Brain Cancer Canada
TORONTO, Oct. 24, 2021 (GLOBE NEWSWIRE) -- Brain Cancer Canada has issued a $100,000 grant to Canadian research exploring new frontiers of brain cancer treatment. Drs. Cynthia Hawkins and Roman...